Breaking News Instant updates and real-time market news.

09:25
01/07/20
01/07
09:25
01/07/20
09:25

UBS freight transport analyst to hold an analyst/industry conference call

Freight Transports Analyst Wadewitz provides and industry outlook for 2020 and discusses which transport stocks offer the greatest opportunity for outperformance in 2020 on an Analyst/Industry conference call to be held on January 7 at 10 am .

TODAY'S FREE FLY STORIES

Hot Stocks
Renalytix AI announces commercial launch of KidneyIntelX test platform » 07:07
09/18/20
09/18
07:07
09/18/20
07:07
RNLX

Renalytix AI

$13.40 /

-1 (-6.94%)

Renalytix AI announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RNLX Renalytix AI
$13.40 /

-1 (-6.94%)

RNLX Renalytix AI
$13.40 /

-1 (-6.94%)

08/11/20 JPMorgan
Renalytix AI initiated with a Neutral at JPMorgan
08/11/20 Stifel
Renalytix AI initiated with a Buy at Stifel
  • 17
    Jul
RNLX Renalytix AI
$13.40 /

-1 (-6.94%)

Hot Stocks
Deciphera presents nine month follow-up data from INVICTUS study at ESMO » 07:06
09/18/20
09/18
07:06
09/18/20
07:06
DCPH

Deciphera

$52.58 /

+0.91 (+1.76%)

Deciphera announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DCPH Deciphera
$52.58 /

+0.91 (+1.76%)

DCPH Deciphera
$52.58 /

+0.91 (+1.76%)

04:57 Today Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/17/20 Piper Sandler
Piper says Deciphera update 'another positive' for rebastinib program
09/14/20 JPMorgan
Deciphera resumed with a Neutral at JPMorgan
08/04/20 Piper Sandler
Piper Sandler remain buyers of Deciphera following 'massive' Qinlock beat
DCPH Deciphera
$52.58 /

+0.91 (+1.76%)

  • 14
    Feb
Hot Stocks
Achieve Life: Results from cytisinicline vs. chantix study presented at SRNT-E » 07:05
09/18/20
09/18
07:05
09/18/20
07:05
ACHV

Achieve Life Sciences

$11.00 /

+0.98 (+9.78%)

Achieve Life Sciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACHV Achieve Life Sciences
$11.00 /

+0.98 (+9.78%)

ACHV Achieve Life Sciences
$11.00 /

+0.98 (+9.78%)

09/17/20 Lake Street
Achieve Life Sciences initiated with a Buy at Lake Street
02/25/20 H.C. Wainwright
Achieve Life Sciences initiated with a Buy at H.C. Wainwright
ACHV Achieve Life Sciences
$11.00 /

+0.98 (+9.78%)

General news
FX Update: The dollar and more especially the yen lifted » 07:05
09/18/20
09/18
07:05
09/18/20
07:05

FX Update: The dollar and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Ayala Pharmaceuticals presents interim data from Phase 2 ACCURACY trial of AL101 » 07:05
09/18/20
09/18
07:05
09/18/20
07:05
AYLA

Ayala Pharmaceuticals

$13.73 /

+1.28 (+10.28%)

Ayala Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AYLA Ayala Pharmaceuticals
$13.73 /

+1.28 (+10.28%)

AYLA Ayala Pharmaceuticals
$13.73 /

+1.28 (+10.28%)

06/10/20
Fly Intel: Top five analyst initiations
06/10/20 Raymond James
Ayala Pharmaceuticals initiated with an Outperform at Raymond James
06/09/20 Raymond James
Ayala Pharmaceuticals initiated with an Outperform at Raymond James
06/02/20 Jefferies
Ayala Pharmaceuticals initiated with a Hold at Jefferies
AYLA Ayala Pharmaceuticals
$13.73 /

+1.28 (+10.28%)

  • 08
    May
AYLA Ayala Pharmaceuticals
$13.73 /

+1.28 (+10.28%)

Recommendations
Baidu on track to return to revenue growth in Q4, says Mizuho » 07:04
09/18/20
09/18
07:04
09/18/20
07:04
BIDU

Baidu

$124.72 /

-1.32 (-1.05%)

Mizuho analyst James Lee…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIDU Baidu
$124.72 /

-1.32 (-1.05%)

BIDU Baidu
$124.72 /

-1.32 (-1.05%)

08/17/20 KeyBanc
Baidu price target raised to $155 from $145 at KeyBanc
08/17/20 Barclays
Baidu price target lowered to $130 from $136 at Barclays
07/28/20 Mizuho
Baidu price target lowered to $170 from $175 at Mizuho
07/02/20 Loop Capital
iQIYI price target raised to $23 from $20 at Loop Capital
BIDU Baidu
$124.72 /

-1.32 (-1.05%)

BIDU Baidu
$124.72 /

-1.32 (-1.05%)

BIDU Baidu
$124.72 /

-1.32 (-1.05%)

BIDU Baidu
$124.72 /

-1.32 (-1.05%)

Hot Stocks
Blackstone announces formation of new portfolio company, ClearGen » 07:03
09/18/20
09/18
07:03
09/18/20
07:03
BX

Blackstone

$52.16 /

-1.36 (-2.54%)

Blackstone said in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BX Blackstone
$52.16 /

-1.36 (-2.54%)

BX Blackstone
$52.16 /

-1.36 (-2.54%)

06/25/20
Fly Intel: Top five analyst initiations
06/25/20 UBS
Blackstone initiated with a Buy at UBS
06/08/20 Citi
Citi downgrades Alternative Asset Managers to Market Weight, lowers four ratings
06/08/20 Citi
Blackstone downgraded to Neutral from Buy at Citi
BX Blackstone
$52.16 /

-1.36 (-2.54%)

BX Blackstone
$52.16 /

-1.36 (-2.54%)

BX Blackstone
$52.16 /

-1.36 (-2.54%)

BX Blackstone
$52.16 /

-1.36 (-2.54%)

Recommendations
Herman Miller price target raised to $40 from $30 at Benchmark » 07:02
09/18/20
09/18
07:02
09/18/20
07:02
MLHR

Herman Miller

$34.57 /

+8.71 (+33.68%)

Benchmark analyst Reuben…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MLHR Herman Miller
$34.57 /

+8.71 (+33.68%)

MLHR Herman Miller
$34.57 /

+8.71 (+33.68%)

09/17/20 Sidoti
Herman Miller price target raised to $50 from $33 at Sidoti
06/30/20 Sidoti
Herman Miller upgraded to Buy from Neutral at Sidoti
05/22/20 Benchmark
Herman Miller initiated with a Buy at Benchmark
03/19/20 Sidoti
Herman Miller downgraded to Neutral from Buy at Sidoti
MLHR Herman Miller
$34.57 /

+8.71 (+33.68%)

MLHR Herman Miller
$34.57 /

+8.71 (+33.68%)

MLHR Herman Miller
$34.57 /

+8.71 (+33.68%)

Earnings
Checkmate Pharmaceuticals reports Q2 net loss $8.3M vs. $6.9M last year » 07:02
09/18/20
09/18
07:02
09/18/20
07:02
CMPI

Checkmate Pharmaceuticals

$11.50 /

+ (+0.00%)

"This is an exciting…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CMPI Checkmate Pharmaceuticals
$11.50 /

+ (+0.00%)

09/01/20 Jefferies
Checkmate Pharmaceuticals initiated with a Buy at Jefferies
09/01/20 BofA
BofA starts Checkmate Pharmaceuticals at Neutral ahead of more 'de-risking'
09/01/20 BofA
Checkmate Pharmaceuticals initiated with a Neutral at BofA
09/01/20 BTIG
Checkmate Pharmaceuticals initiated with a Buy at BTIG
  • 07
    Aug
CMPI Checkmate Pharmaceuticals
$11.50 /

+ (+0.00%)

Hot Stocks
SSR Mining sees 2020 production of 680,000-760,000 gold equivalent » 07:01
09/18/20
09/18
07:01
09/18/20
07:01
SSRM

SSR Mining

$22.44 /

+0.18 (+0.81%)

SSR Mining announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SSRM SSR Mining
$22.44 /

+0.18 (+0.81%)

SSRM SSR Mining
$22.44 /

+0.18 (+0.81%)

09/17/20 National Bank
SSR Mining coverage resumed with an Outperform at National Bank
09/17/20 Scotiabank
SSR Mining upgraded to Outperform from Sector Perform at Scotiabank
07/21/20 Canaccord
SSR upgraded to Buy with 19% potential upside at Canaccord
07/21/20 Canaccord
SSR Mining upgraded to Buy from Hold at Canaccord
SSRM SSR Mining
$22.44 /

+0.18 (+0.81%)

SSRM SSR Mining
$22.44 /

+0.18 (+0.81%)

SSRM SSR Mining
$22.44 /

+0.18 (+0.81%)

SSRM SSR Mining
$22.44 /

+0.18 (+0.81%)

Recommendations
Dow Inc. price target raised to $56 from $55 at Deutsche Bank » 07:00
09/18/20
09/18
07:00
09/18/20
07:00
DOW

Dow Inc.

$51.00 /

+1.31 (+2.64%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DOW Dow Inc.
$51.00 /

+1.31 (+2.64%)

DOW Dow Inc.
$51.00 /

+1.31 (+2.64%)

09/16/20
Fly Intel: Top five analyst downgrades
09/16/20 HSBC
HSBC downgrades Dow to Reduce on 'broken' growth model
09/16/20 HSBC
Dow Inc. downgraded to Reduce from Hold at HSBC
09/11/20 JPMorgan
JPMorgan upgrades LyondellBasell as way to play petrochemical market
DOW Dow Inc.
$51.00 /

+1.31 (+2.64%)

DOW Dow Inc.
$51.00 /

+1.31 (+2.64%)

DOW Dow Inc.
$51.00 /

+1.31 (+2.64%)

DOW Dow Inc.
$51.00 /

+1.31 (+2.64%)

Initiation
Macom initiated with a Buy at Benchmark » 06:58
09/18/20
09/18
06:58
09/18/20
06:58
MTSI

Macom

$32.76 /

-0.25 (-0.76%)

Benchmark analyst Ruben…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MTSI Macom
$32.76 /

-0.25 (-0.76%)

09/11/20 Piper Sandler
Macom pullback a buying opportunity, says Piper Sandler
07/30/20 Northland
Macom price target raised to $45 from $38 at Northland
07/30/20 Craig-Hallum
Macom price target raised to $53 from $40 at Craig-Hallum
07/30/20 Piper Sandler
Macom price target raised to $47 from $37 at Piper Sandler
MTSI Macom
$32.76 /

-0.25 (-0.76%)

MTSI Macom
$32.76 /

-0.25 (-0.76%)

Hot Stocks
Takeda Pharmaceutical, Foundation Medicine announce collaboration » 06:58
09/18/20
09/18
06:58
09/18/20
06:58
TAK

Takeda Pharmaceutical

$18.83 /

+0.1 (+0.53%)

Foundation Medicine and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TAK Takeda Pharmaceutical
$18.83 /

+0.1 (+0.53%)

TAK Takeda Pharmaceutical
$18.83 /

+0.1 (+0.53%)

06/18/20 RBC Capital
Neurocrine price target raised to $135 from $116 at RBC Capital
06/17/20 Oppenheimer
Takeda deal expands Neurocrine's pipeline into psychiatry, says Oppenheimer
04/20/20 SVB Leerink
Ascendis Pharma price target raised to $170 from $152 at SVB Leerink
03/25/20 Piper Sandler
Piper Sandler backs Overweight on 'well capitalized' Exelixis
TAK Takeda Pharmaceutical
$18.83 /

+0.1 (+0.53%)

TAK Takeda Pharmaceutical
$18.83 /

+0.1 (+0.53%)

TAK Takeda Pharmaceutical
$18.83 /

+0.1 (+0.53%)

Recommendations
Voya Financial has 85% upside on Citi's 'blue sky' market value » 06:57
09/18/20
09/18
06:57
09/18/20
06:57
VOYA

Voya Financial

$47.84 /

-0.25 (-0.52%)

Citi analyst Suneet…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VOYA Voya Financial
$47.84 /

-0.25 (-0.52%)

VOYA Voya Financial
$47.84 /

-0.25 (-0.52%)

08/18/20
Fly Intel: Top five analyst initiations
08/18/20 Wells Fargo
Wells Fargo starts Voya Financial with Overweight, $62 price target
08/18/20 Wells Fargo
Voya Financial initiated with an Overweight at Wells Fargo
08/13/20 Truist
Voya Financial price target raised to $53 from $45 at Truist
VOYA Voya Financial
$47.84 /

-0.25 (-0.52%)

VOYA Voya Financial
$47.84 /

-0.25 (-0.52%)

Hot Stocks
Takeda Pharmaceutical presents data from lung cancer portfolio at ESMO » 06:56
09/18/20
09/18
06:56
09/18/20
06:56
TAK

Takeda Pharmaceutical

$18.83 /

+0.1 (+0.53%)

Takeda Pharmaceutical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TAK Takeda Pharmaceutical
$18.83 /

+0.1 (+0.53%)

TAK Takeda Pharmaceutical
$18.83 /

+0.1 (+0.53%)

06/18/20 RBC Capital
Neurocrine price target raised to $135 from $116 at RBC Capital
06/17/20 Oppenheimer
Takeda deal expands Neurocrine's pipeline into psychiatry, says Oppenheimer
04/20/20 SVB Leerink
Ascendis Pharma price target raised to $170 from $152 at SVB Leerink
03/25/20 Piper Sandler
Piper Sandler backs Overweight on 'well capitalized' Exelixis
TAK Takeda Pharmaceutical
$18.83 /

+0.1 (+0.53%)

TAK Takeda Pharmaceutical
$18.83 /

+0.1 (+0.53%)

TAK Takeda Pharmaceutical
$18.83 /

+0.1 (+0.53%)

Recommendations
ShockWave Medical price target raised to $80 from $59 at Wells Fargo » 06:56
09/18/20
09/18
06:56
09/18/20
06:56
SWAV

ShockWave Medical

$70.65 /

+1.5 (+2.17%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SWAV ShockWave Medical
$70.65 /

+1.5 (+2.17%)

SWAV ShockWave Medical
$70.65 /

+1.5 (+2.17%)

09/15/20 Piper Sandler
ShockWave Medical price target raised to $76 from $58 at Piper Sandler
08/12/20 Canaccord
ShockWave Medical price target raised to $60 from $53 at Canaccord
07/21/20 Piper Sandler
ShockWave '673 patent found to be invalid, says Piper Sandler
07/09/20 Canaccord
ShockWave Medical patent outcome impact minimal, says Canaccord
SWAV ShockWave Medical
$70.65 /

+1.5 (+2.17%)

  • 17
    Jun
  • 15
    Nov
SWAV ShockWave Medical
$70.65 /

+1.5 (+2.17%)

Recommendations
Floor & Decor price target raised to $85 from $80 at Wells Fargo » 06:54
09/18/20
09/18
06:54
09/18/20
06:54
FND

Floor & Decor

$74.60 /

-1.35 (-1.78%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FND Floor & Decor
$74.60 /

-1.35 (-1.78%)

FND Floor & Decor
$74.60 /

-1.35 (-1.78%)

08/07/20 Wedbush
Flooring companies not excluded from tariffs under USTR order, says Wedbush
08/03/20 Loop Capital
Floor & Decor price target raised to $70 from $40 at Loop Capital
08/03/20 BofA
Floor & Decor upgraded to Buy from Neutral at BofA
08/03/20 BofA
Floor & Decor upgraded to Buy from Neutral at BofA
FND Floor & Decor
$74.60 /

-1.35 (-1.78%)

  • 11
    Aug
  • 20
    May
  • 15
    Nov
FND Floor & Decor
$74.60 /

-1.35 (-1.78%)

Hot Stocks
Piedmont Lithium trading halted, news pending  06:54
09/18/20
09/18
06:54
09/18/20
06:54
PLL

Piedmont Lithium

$10.97 /

+2.6 (+31.06%)

 
ShowHide Related Items >><<
PLL Piedmont Lithium
$10.97 /

+2.6 (+31.06%)

PLL Piedmont Lithium
$10.97 /

+2.6 (+31.06%)

05/27/20 Roth Capital
Piedmont Lithium price target lowered to $20 from $28 at Roth Capital
  • 09
    Jun
Recommendations
Societe Generale ups AstraZeneca target, sees earnings tripling in five years » 06:52
09/18/20
09/18
06:52
09/18/20
06:52
AZN

AstraZeneca

$55.93 /

+0.79 (+1.43%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/09/20 SVB Leerink
AstraZeneca COVID vaccine hold may cause ripple, says SVB Leerink
09/08/20 Cantor Fitzgerald
Cantor Fitzgerald starts 'underappreciated' Entasis at Overweight
AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

Recommendations
Canada Goose's China opportunity underappreciated by market, says UBS » 06:50
09/18/20
09/18
06:50
09/18/20
06:50
GOOS

Canada Goose

$28.74 /

+0.225 (+0.79%)

UBS analyst Jay Sole…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOOS Canada Goose
$28.74 /

+0.225 (+0.79%)

GOOS Canada Goose
$28.74 /

+0.225 (+0.79%)

09/10/20 Exane BNP Paribas
Canada Goose initiated with an Underperform at Exane BNP Paribas
08/12/20 RBC Capital
Canada Goose price target lowered to C$43 from C$47 at RBC Capital
08/12/20 Baird
Canada Goose attractive for patient investors, says Baird
08/12/20 RBC Capital
Canada Goose price target lowered to C$43 from C$47 at RBC Capital
GOOS Canada Goose
$28.74 /

+0.225 (+0.79%)

GOOS Canada Goose
$28.74 /

+0.225 (+0.79%)

GOOS Canada Goose
$28.74 /

+0.225 (+0.79%)

GOOS Canada Goose
$28.74 /

+0.225 (+0.79%)

Upgrade
Morgan Stanley upgrades II-VI to Overweight on diversification » 06:50
09/18/20
09/18
06:50
09/18/20
06:50
IIVI

II-VI

$37.88 /

-0.72 (-1.87%)

, LITE

Lumentum

$70.80 /

-0.57 (-0.80%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IIVI II-VI
$37.88 /

-0.72 (-1.87%)

LITE Lumentum
$70.80 /

-0.57 (-0.80%)

IIVI II-VI
$37.88 /

-0.72 (-1.87%)

05:06 Today Morgan Stanley
II-VI upgraded to Overweight from Equal Weight at Morgan Stanley
09/08/20 Citi
II-VI initiated with a Buy at Citi
09/04/20 Morgan Stanley
Ciena price target lowered to $46 from $50 at Morgan Stanley
08/14/20 DA Davidson
II-VI price target raised to $60 from $45 at DA Davidson
LITE Lumentum
$70.80 /

-0.57 (-0.80%)

09/16/20 Barclays
Lumentum price target lowered to $90 from $105 at Barclays
09/14/20 Susquehanna
Lumentum weakness a buying opportunity, says Susquehanna
09/10/20 Northland
Next gen ROADMs potential not priced into Lumentum shares, says Northland
09/04/20 Morgan Stanley
Ciena price target lowered to $46 from $50 at Morgan Stanley
IIVI II-VI
$37.88 /

-0.72 (-1.87%)

LITE Lumentum
$70.80 /

-0.57 (-0.80%)

  • 02
    Jul
IIVI II-VI
$37.88 /

-0.72 (-1.87%)

LITE Lumentum
$70.80 /

-0.57 (-0.80%)

IIVI II-VI
$37.88 /

-0.72 (-1.87%)

LITE Lumentum
$70.80 /

-0.57 (-0.80%)

LITE Lumentum
$70.80 /

-0.57 (-0.80%)

Hot Stocks
Astellas Pharma, Seattle Genetics announce Padcev trial meets primary endpoint » 06:50
09/18/20
09/18
06:50
09/18/20
06:50
ALPMY

Astellas Pharma

$0.00 /

+ (+0.00%)

, SGEN

Seattle Genetics

$175.77 /

-0.995 (-0.56%)

Astellas Pharma (ALPMY)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALPMY Astellas Pharma
$0.00 /

+ (+0.00%)

SGEN Seattle Genetics
$175.77 /

-0.995 (-0.56%)

ALPMY Astellas Pharma
$0.00 /

+ (+0.00%)

05/26/20 Goldman Sachs
Astellas Pharma upgraded to Buy on raised PADCEV estimates at Goldman Sachs
05/26/20 Goldman Sachs
Astellas Pharma upgraded to Buy from Neutral at Goldman Sachs
01/23/20 Morgan Stanley
Astellas Pharma resumed with an Overweight at Morgan Stanley
12/05/19 JPMorgan
Audentes Therapeutics downgraded to Neutral from Overweight at JPMorgan
SGEN Seattle Genetics
$175.77 /

-0.995 (-0.56%)

04:57 Today Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/15/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
09/14/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
SGEN Seattle Genetics
$175.77 /

-0.995 (-0.56%)

SGEN Seattle Genetics
$175.77 /

-0.995 (-0.56%)

Hot Stocks
Merck, AZN announce 'positive' five-year follow-up data from Phase 3 SOLO-1 » 06:50
09/18/20
09/18
06:50
09/18/20
06:50
MRK

Merck

$85.65 /

+0.01 (+0.01%)

, AZN

AstraZeneca

$55.93 /

+0.79 (+1.43%)

AstraZeneca (AZN) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$85.65 /

+0.01 (+0.01%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

MRK Merck
$85.65 /

+0.01 (+0.01%)

09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/14/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
09/14/20 Piper Sandler
Seattle Genetics price target raised to $172 from $165 at Piper Sandler
08/11/20 H.C. Wainwright
Pfenex acquisition fits well with Ligand growing portfolio, says H.C. Wainwright
AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/09/20 SVB Leerink
AstraZeneca COVID vaccine hold may cause ripple, says SVB Leerink
09/08/20 Cantor Fitzgerald
Cantor Fitzgerald starts 'underappreciated' Entasis at Overweight
MRK Merck
$85.65 /

+0.01 (+0.01%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

MRK Merck
$85.65 /

+0.01 (+0.01%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

MRK Merck
$85.65 /

+0.01 (+0.01%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

MRK Merck
$85.65 /

+0.01 (+0.01%)

AZN AstraZeneca
$55.93 /

+0.79 (+1.43%)

Upgrade
JPMorgan upgrades Alstom to Overweight on upside from BT deal » 06:49
09/18/20
09/18
06:49
09/18/20
06:49
ALSMY

Alstom

$0.00 /

+ (+0.00%)

JPMorgan analyst Akash…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALSMY Alstom
$0.00 /

+ (+0.00%)

ALSMY Alstom
$0.00 /

+ (+0.00%)

04:45 Today JPMorgan
Alstom upgraded to Overweight from Neutral at JPMorgan
08/03/20 Commerzbank
Alstom initiated with a Buy at Commerzbank
07/20/20 JPMorgan
Alstom price target raised to EUR 44 from EUR 38 at JPMorgan
07/17/20 UBS
Alstom price target raised to EUR 55 from EUR 48 at UBS
ALSMY Alstom
$0.00 /

+ (+0.00%)

Periodicals
Belgium-based Ontex looks to buy Domtar's personal-care unit, Bloomberg reports » 06:48
09/18/20
09/18
06:48
09/18/20
06:48
UFS

Domtar

$28.07 /

+1.915 (+7.32%)

Belgium-based personal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UFS Domtar
$28.07 /

+1.915 (+7.32%)

UFS Domtar
$28.07 /

+1.915 (+7.32%)

08/14/20
Fly Intel: Top five analyst upgrades
08/14/20 Citi
Domtar upgraded to Buy from Neutral at Citi
08/13/20 Citi
Domtar upgraded to Buy from Neutral at Citi
08/10/20 RBC Capital
Domtar price target raised to $26 from $21 at RBC Capital
UFS Domtar
$28.07 /

+1.915 (+7.32%)

UFS Domtar
$28.07 /

+1.915 (+7.32%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.